CARIS LIFE SCIENCES, INC. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CARIS LIFE SCIENCES, INC. treasury stock, shares, acquired for the quarter ending 2025-12-31 was -8.93K shares.
- CARIS LIFE SCIENCES, INC. treasury stock, shares, acquired for the quarter ending 2025-09-30 was 0.00 shares.
- CARIS LIFE SCIENCES, INC. treasury stock, shares, acquired for fiscal 2025 was 1.43M shares.
- CARIS LIFE SCIENCES, INC. treasury stock, shares, acquired for fiscal 2024 was 0.00 shares.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2025-12-31 | -8.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 1.43M shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | |
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |